A range of new mental health treatments are available to Western medicine, and practitioners are figuring out how to use them effectively. Matt Brockmeier, co-founder and chief legal officer at Entheogyn and of counsel at Antithesis Law, joins Rebecca Nicholson, foundation director and wellness advisor at Prime Quadrant, to explore this evolving
The Healthcare Investor Blogs
Blog Authors
Latest from The Healthcare Investor
Healthcare & Life Sciences Private Equity Deal Tracker: Patient Square Acquires Premier
Patient Square Capital has announced its acquisition of Premier Inc.
Premier, formed in 1996 and based in Charlotte, North Carolina, is a healthcare service company well known for its group purchasing organization services, but also offering technology, data analytics, advisory and performance improvement solutions.
Patient Square, based in Menlo Park, Calif., is dedicated…
Healthcare & Life Sciences Private Equity Deal Tracker: Vance Street Acquires Injectech
Vance Street Capital has announced its acquisition of Injectech from The West Group (TWG).
Injectech, founded in 1998 and based in Fort Collins, Colorado, is a manufacturer of luer locks, bond-in luers, check valves, tube to tube connectors and spikes for the medical industry.
Vance Street, founded in 2007 and based in Los…
Healthcare & Life Sciences Private Equity Deal Tracker: H.I.G. Capital Invests in GT Independence
H.I.G. Capital has announced an investment in GT Independence.
GT, founded in 2004 and based in Sturgis, Michigan, is a provider of long-term home care and support solutions for Medicaid participants.
H.I.G., founded in 1993 and based in Miami, pursues a wide range of investments in healthcare and many other industries. The firm…
Healthcare & Life Sciences Private Equity Deal Tracker: Sheridan Sells Tarrytown Expocare to Carlyle
Sheridan Capital Partners has sold Tarrytown Expocare Pharmacy to Carlyle, according to a news release.
Tarrytown, founded in 2007 and based in Austin, Texas, is a long-term care pharmacy specialized in serving individuals with intellectual and developmental disabilities. The company states that it is licensed in more than 40 states.
Sheridan, founded…
Healthcare & Life Sciences Private Equity Deal Tracker: OEP Exits InfuCare Rx
One Equity Partners (OEP) has announced the exit from its investment in InfuCare Rx through a strategic founder-led equity buyback.
InfuCare, founded in 2014 and based in Fairfield, New Jersey, is a specialty infusion therapy services provider for patients with complex conditions.
OEP, founded in 2001 and based in New York, is a…
Healthcare & Life Sciences Private Equity Deal Tracker: Diversis Acquires Three Healthcare Technology Companies
Diversis Capital has announced the acquisitions of three technology companies serving the hospital supply chain management market:
- Kermit, a cloud-based, bill-only automation, spend-management and analytics platform for physician preference items;
- Meperia, a supply chain and procurement intelligence platform; and
- Genesis Automation Healthcare, a clinical traceability and supply chain automation solution.
The combined three…
Healthcare & Life Sciences Private Equity Deal Tracker: JLL Acquires Parks Medical Electronics
JLL Partners has announced its acquisition of Parks Medical Electronics.
Parks, established in 1961 and based in Aloha, Oregon, is a manufacturer of Doppler ultrasound systems and vascular labs. Its products, including the Flo-Lab system, are used in medical offices, operating rooms and veterinary practices.
JLL, founded in 1988 and based in New…
Healthcare & Life Sciences Private Equity Deal Tracker: WindRose to Sell BPD to MJH
WindRose Health Investors has announced it completed the sale of BPD Healthcare to MJH Life Sciences.
BPD, founded in 2002 and based in Boca Raton, Florida, is a healthcare marketing services firm.
WindRose, founded in 2000 and based in New York, pursues equity investments in healthcare companies. The firm invests in a broad…
Healthcare & Life Sciences Private Equity Deal Tracker: TPG and Blackstone to Acquire Hologic
TPG and Blackstone will acquire Hologic, according to a news release. The deal is valued at up to $18.3 billion.
Hologic (Nasdaq: HOLX), founded in 1985 and based in Marlborough, Massachusetts, is a women’s health technology firm.
TPG, founded in 1992 and based in San Francisco, targets investments in middle market companies. The firm…